Sign In

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.


BAC BV collaborates with Life Technologies to provide new HPLC affinity columns

Naarden, The Netherlands, 21 June 2011 – BAC BV, the leading provider of antibody-based affinity purification technology, has announced a strategic collaboration with Life Technologies, the global manufacturer of molecular diagnostic and research-use products, to bring the wide range of BAC’s CaptureSelect® affinity ligand specificities to Life Technologies’ POROS® chromatography media and pre-packed HPLC columns. This new suite of products will provide an unparalleled range of specificities and column formats for applications from discovery through to process monitoring.

The collaboration will create a range of ready-to-use HPLC columns pre-packed with CaptureSelect affinity ligands immobilized on POROS chromatography media. Designed for the high pressures and flow rates necessary to provide the real-time results demanded for biopharmaceutical quality assurance needs, the unique selectivity of these columns will support Process Analytical Technology (PAT) for virtually any biopharmaceutical manufacturing process.

“We are very excited to be able to provide a continuously evolving range of specificities and column formats that will allow more researchers to access the benefits of CaptureSelect technology”, commented Laurens Sierkstra, CEO of BAC. “Scientists will be able to routinely use CaptureSelect ligands in formats that support QbD approaches for process development and monitoring.”


About BAC BV
BAC discovers, develops and manufactures affinity ligands and affinity purification products to support biopharmaceutical research and production. BAC’s CaptureSelect affinity purification and separation products are provided for the discovery, preclinical and clinical manufacturing of therapeutic proteins, including antibodies and antibody fragments. These products enable a reduced time to market, increased purity and yield and an overall lower cost of goods for biopharmaceutical drug development. BAC BV was established in 1995 as a Unilever subsidiary. Currently the Company employs 37 people with an R&D laboratory facility in Leiden and a state-of-the-art ISO 9001 certified manufacturing plant in Naarden, the Netherlands.
For more information about BAC, visit our website at For more information about CaptureSelect® products, visit our website at

For additional information, please contact:

College Hill Life Sciences
Dr Lynne Trowbridge, Dr Anastasios Koutsos
+44 20-7457-2020

Publisher Contact Information:

College Hill Life Sciences
+44 20-7457-2020

Company profile of Bio Affinity Company (BAC) (acquired by Life Technologies)
Past press releases of Bio Affinity Company (BAC) (acquired by Life Technologies).


Tech investments
From our Online Data Service
VC-backed companies
From our Radar

Recent Deals

Dec 21€50.0MKnowledge management
Dec 20€16.0MSemiconductors
Dec 17€18.0MOther Computers & Electronics
Dec 17€5.2MBiotechnology
Dec 17€17.0MBusiness applications
Dec 15€17.0ME-Commerce
Dec 4€3.3MNanotechnology

For information on Europe's most extensive database on technology funding click here!


Press Releases

Sep 30
tetavi raises $6 million to help more companies bring 3d holograms ...

May 28
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
nethone raised over $1 million from innovation nest

Mar 31
the fit allocates chf 100'000 to comppair technologies

Jan 29
yumpingo raises $10m to transform guest experiences in restaurants

About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.